Clinical Trial Update: FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis [NA]

View source ↗

Summary

An ongoing clinical trial at Peking University First Hospital is evaluating a fibroblast activation protein (FAP) targeted PET/CT tracer for noninvasive monitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Fibrosis

Drugs mentioned

• FAP-targeting PET tracer for renal fibrosis

Snippet

Sponsor: Peking University First Hospital | Conditions: CKD, Renal Fibrosis | NA | Status: ENROLLING_BY_INVITATION